Multidrug-resistant organism colonisation and infection in paediatric patients from Ukraine receiving specialised care in Germany: a multicentre study
Abstract Purpose Children with chronic medical conditions are at increased risk of colonisation and infection with multidrug-resistant organisms (MDROs) because of repeated healthcare exposure and antimicrobial use. We aimed to characterise MDRO-positive screening findings and documented MDRO infections among paediatric patients from Ukraine receiving specialised care in Germany. Methods We conducted a multicentre retrospective study at ten tertiary paediatric centres in Germany between 24 February 2022 and 31 March 2023. Eligible patients were 28 days to < 18 years, had resided in Ukraine for ≥ 3 months, had previously received medical care in Ukraine for a chronic medical condition or war-related injury, and underwent MDRO screening. Resistance phenotypes were classified using the German Multidrug-Resistant Gram-Negative bacteria (MRGN) classification. Results Among 198 children, 85 (43%) had at least one MDRO-positive screening result. Multidrug-resistant Gram-negative organisms predominated; 44% of colonisation events were 3MRGN and 19% were 4MRGN, indicating carbapenem resistance. Twenty-three of 85 MDRO-positive children (27%) had a clinically documented MDRO infection, and in 21/ 23 episodes (91%) the same species with a compatible resistance phenotype had been identified in a preceding screening sample. No in-hospital deaths occurred; six infected patients (26%) had newly documented residual impairment at discharge. None of the participating centres performed complete multisite screening as recommended by the German Society for Paediatric Infectious Diseases. Conclusions MDRO-positive screening findings and infections were common in this selected cohort. Risk-adapted admission screening may inform IPC and empirical treatment decisions. These findings may also apply to children with previous healthcare exposure in other high-prevalence settings.
Authors
- Horst von Bernuth (ORCID: https://orcid.org/0000-0002-5812-7675)
- Benedikt Daniel Spielberger (ORCID: https://orcid.org/0000-0002-0300-0730)
- Ursula Felderhoff‐Müser (ORCID: https://orcid.org/0000-0002-7765-8893)
- Leandra Forchert
- Ulf Schulze‐Sturm (ORCID: https://orcid.org/0000-0001-9539-5356)
- Sarah Christina Goretzki (ORCID: https://orcid.org/0000-0001-5218-070X)
- Petra Kaiser‐Labusch (ORCID: https://orcid.org/0000-0002-3229-6083)
- Robin Kobbe (ORCID: https://orcid.org/0000-0001-6067-3408)
- Giovanni-Battista Fucini (ORCID: https://orcid.org/0000-0002-1097-5069)
- Till Dresbach (ORCID: https://orcid.org/0000-0001-7074-7933)
- Jan Dziobaka
- Tom Hühne (ORCID: https://orcid.org/0009-0007-4389-0903)
- Luise Martin (ORCID: https://orcid.org/0000-0001-6936-1574)
- Martina Stiefel (ORCID: https://orcid.org/0009-0002-3277-7212)
- Olaf Beck (ORCID: https://orcid.org/0000-0002-7448-6029)
- Melanie Anger
- Simone Schrauth (ORCID: https://orcid.org/0000-0003-4872-9733)
- Christian Dohna-Schwake
- Clara Held
- Alina Frolova
Institutions
- University of Freiburg (DE)
- University of Würzburg (DE)
- University Hospital Bonn (DE)
- Humboldt-Universität zu Berlin (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Universitätsklinikum Würzburg (DE)
- University Hospital in Halle (DE)
- Stiftung Universitätsmedizin Essen (DE)
- University of Duisburg-Essen (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
- Bernhard Nocht Institute for Tropical Medicine (DE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11284596/v1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- preprint